MediciNova announces update on phase 2b trial
MediciNova announces update on phase 2b trial
MediciNova has announced that the ongoing clinical trial of MN-166 (ibudilast) in patients with progressive multiple sclerosis (PMS) has finished the randomisation of 255 patients, exceeding the initial goal of 250 patients........ Read More - http://www.ms-uk.org/MN-166
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1255 Views
-
Last post by frodo
-
- 0 Replies
- 1658 Views
-
Last post by NHE
-
- 1 Replies
- 2956 Views
-
Last post by Tif
-
- 2 Replies
- 4154 Views
-
Last post by DIM
-
- 0 Replies
- 2345 Views
-
Last post by NHE
-
- 0 Replies
- 2332 Views
-
Last post by NHE
-
- 0 Replies
- 1292 Views
-
Last post by frodo
-
- 0 Replies
- 1244 Views
-
Last post by frodo
-
- 0 Replies
- 1263 Views
-
Last post by frodo